Also Cyp has treated 165 patients in Osteoarthritis without generating an adverse event worthy of reporting. And these 165 patients received multiple injections. So we’re looking at close to 400 doses of Cymerus cells without triggering an event that would halt recruitment.
- Forums
- ASX - By Stock
- Ann: Encouraging Initial Data from CYP-006TK DFU Trial
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

Also Cyp has treated 165 patients in Osteoarthritis without...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $10.82K | 65.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 88474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 0.165 |
1 | 30000 | 0.160 |
3 | 56451 | 0.155 |
5 | 136673 | 0.150 |
2 | 45937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 88474 | 2 |
0.175 | 77450 | 2 |
0.180 | 108494 | 4 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
Last trade - 15.32pm 20/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |